Peter Svennilson
CIK 1606074 · last filed 2023-01-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$201.24M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$56.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | 11,203,333 | $1.54 | $17.25M | $72.49M | 36 | 2023-01-17 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 193,426 | $58.01 | $11.22M | -$43.47M | 7 | 2022-05-27 |
| ORIC | Director | 4,616,666 | $11.91 | $54.98M | $0 | 3 | 2021-06-17 |
| RVMD | Director | 705,313 | $183.86 | $129.68M | -$84.23M | 6 | 2021-04-28 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | 2,604,528 | $33.99 | $88.53M | -$1.11M | 2 | 2021-02-19 |
| NRIX | 10%+ Owner | 686,274 | $24.15 | $16.57M | $0 | 1 | 2020-07-29 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 3,102,934 | $0.03 | $99.9K | $0 | 2 | 2019-06-20 |
Recent Filings · Page 2 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-19 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Sell (S) | −30,000 | -$1.11M | EDGAR |
| 2020-12-11 | RVMD | Other (J) | −986,886 | $0 | EDGAR |
| 2020-11-18 | RVMD | Sell (S) | −2,027,156 | -$73.79M | EDGAR |
| 2020-09-22 | RAPT Therapeutics, Inc. (RAPT) Delisted | Sell (S) | −608,000 | -$18.76M | EDGAR |
| 2020-08-19 | RAPT Therapeutics, Inc. (RAPT) Delisted | Sell (S) | −538,654 | -$12.25M | EDGAR |
| 2020-07-29 | NRIX | Conv (C) | +13,345,096 | $0 | EDGAR |
| 2020-07-28 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +435,498 | $7.81M | EDGAR |
| 2020-06-19 | RVMD | Grant (A) | +7,234 | $0 | EDGAR |
| 2020-06-19 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-28 | ORIC | Conv (C) | +4,693,181 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.